as on October 17, 2025 at 4:01 pm IST
Day's Low
Day's High
0.33%
Downside
1.94%
Upside
52 Week's Low
52 Week's High
27.47%
Downside
62.58%
Upside
as on October 17, 2025 at 4:01 pm IST
Market Cap
₹1,457.82 Cr
Return on Equity (ROE)
9.77
PE Ratio (TTM)
37.73
Return on capital employed (ROCE)
9.47
Industry PE ratio
41.74
Beta (LTM)
0.76
P/B Ratio
3.15
Dividend Yield
0.56
PEG Ratio
1.92
Quarterly Earnings Growth YOY
130.97
EPS (TTM)
33.89
Sector
Pharmaceuticals
Book Value
369.41
Technical Analysis
Bearish
View Technical Analysis
as on October 17, 2025 at 4:01 pm IST
Hester Biosciences Ltd in the last 5 years
Lowest (19.52x)
March 23, 2020
Today (37.73x)
October 17, 2025
Industry (41.74x)
October 17, 2025
Highest (124.52x)
July 26, 2024
Today’s Price to Earnings Ratio: 37.73x
Compare market cap, revenue, PE, and other key metrics of Hester Biosciences Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 1,457.82 | -0.61% | 0.74 | 28 | 311 | |
NA | 13.33 | 57.33% | 0.00 | -1 | NA | |
NA | 111.10 | -10.14% | 0.70 | 6 | 318 | |
NA | 172.53 | 99.46% | 0.69 | -14 | 19 | |
BUY | 4,759.02 | -6.59% | 0.66 | 168 | 2,387 |
Search interest for Hester Biosciences Ltd Stock has decreased by -46% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Hester Biosciences Ltd.
Hester Biosciences Ltd’s net profit jumped 159.31% since last year same period to ₹16.44Cr in the Q1 2025-2026. On a quarterly growth basis, Hester Biosciences Ltd has generated 1174.42% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Hester Biosciences Ltd has declared dividend of ₹7.00 per share on 09 May 2025 - translating a dividend yield of 0.76%.
Read More about DividendsCheck stock indices that include Hester Biosciences Ltd.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 0.04% to 0.53% in Sep 2025 quarter
Retail Holding Up
Retail Investor have increased holdings from 45.73% to 45.74% in Sep 2025 quarter
Revenue Rich
Revenue is up for the last 3 quarters, 72.0 Cr → 87.47 Cr (in ₹), with an average increase of 9.2% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, 1.29 Cr → 16.44 Cr (in ₹), with an average increase of 92.2% per quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 10.0% return, outperforming this stock by 38.8%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 129.3% return, outperforming this stock by 143.7%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 53.73% of holdings in Sep 2025 quarter
Price Dip
In the last 1 month, HESTERBIO stock has moved down by -15.9%
Organisation | Hester Biosciences Ltd |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Hester Biosciences Ltd share price today stands at ₹1713.7 as on at the close of the market. Hester Biosciences Ltd share today touched a day high of ₹1747 and a low of ₹1708.
Hester Biosciences Ltd touched a 52 week high of ₹2786.1 and a 52 week low of ₹1242.95. Hester Biosciences Ltd share price today i.e. is closed at ₹1713.7, which is -38.49% down from its 52 week high and 37.87% up from its 52 week low.
Hester Biosciences Ltd market capitalisation is ₹1,457.82 Cr as on .
To buy Hester Biosciences Ltd shares, you need to follow these steps:
Hester Biosciences Ltd trading volume is 2,943.00 as on . This means that 2,943.00 shares of Hester Biosciences Ltd were bought and sold on the stock market during today's trading session.